지도교수 | 김건호 |
---|---|
전공분류 | 열 및 물질전달(Heat and Mass Transfer) |
주소 | 50 UNIST-gil, 110-dong, 301-1-ho, Ulsan, South Korea, 44919 |
전화 | |
홈페이지 | https://www.recensmedical.com/ |
Established in 2016, RecensMedical is built with an aspiration to transform and reimagine the treatment options available with our proprietary
precision cooling technology, whereby its efficacy and safety profiles are evident in ophthalmology and dermatology applications thus far.
We are comprised of a team of dedicated and outstanding individuals who strive to provide the finest medical cooling solution out there to enhance both physicians’ practice and patients’ lives.
Before IVI can be administered, several anesthetic methods such as topical anesthesia drops, gel and subconjunctival injection are being used
by retina specialists. Each of this anesthesia has its own limitations such as long onset of action, post-IVI soreness, subconjunctival hemorrhage, or suboptimal anesthetic effect.
Recens Medical’s ocular cooling anesthesia based on precision tissue cooling technology is designed to make IVI a rapid and painless procedure.
Cold temperatures are known to significantly suppress neuronal signal transmission. Our ocular cooling anesthesia provides such cold temperatures with utmost precision to anesthetize patient’s eye at an unprecedented speed and safety. In 10 seconds, sufficient anesthesia is achieved for a painless IVI, enabling anesthesia and injection within a single visit. Recens Medical’s ocular cooling anesthesia is the first-of-kind non-pharmacologic
anesthesia that greatly reduces time exposure of patient’s eye to topical anesthesia, and therefore minimizes complications resulting
from pharmacological anesthesia.
The efficacy and long term safety of ocular cooling anesthesia have been demonstrated with the pilot trial COOL-1 (clinicaltrials.gov: NCT03732287) and ongoing multi-site trial COOL-2 (clinicaltrials.gov: NCT03956797).